Shionogi

Patent cliffs & loss of exclusivity

Japan-based pharmaceutical company focused on the manufacturing and distribution of pharmaceuticals.

Company

Also Known AsShionogi & Co., Ltd.
Legal NameShionogi & Co., Ltd.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/shionogi
Fax Number+81662299596
Full Address1-8, Doshomachi 3-chome Chuo-ku Osaka, 541-0045 Japan
Legal Entity Identifier35380049VXDTHZI3DY35
LinkedIn URLhttps://www.linkedin.com/company/shionogi-&-co.-ltd/

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. FETROJACEFIDEROCOL SULFATE TOSYLATESmall mol.Sep 2035
  2. RADICAVA ORSEDARAVONESmall mol.Nov 2041
  3. XOCOVAENSITRELVIRSmall mol.May 2042
  4. COGNEXTACRINE HYDROCHLORIDESmall mol.—
  5. COGNEXTACRINE HYDROCHLORIDESmall mol.—
  6. COGNEXTACRINE HYDROCHLORIDESmall mol.—
  7. COGNEXTACRINE HYDROCHLORIDESmall mol.—
  8. DORIBAXDORIPENEMSmall mol.—
  9. DORIBAXDORIPENEMSmall mol.—
  10. ULESFIABENZYL ALCOHOLSmall mol.—
  11. RADICAVAEDARAVONESmall mol.—
  12. RADICAVAEDARAVONESmall mol.—
  13. RYBIX ODTTRAMADOL HYDROCHLORIDESmall mol.—
  14. UROBAKSULFAMETHOXAZOLESmall mol.—
  15. UROPLUS DSSULFAMETHOXAZOLE; TRIMETHOPRIMSmall mol.—
  16. UROPLUS SSSULFAMETHOXAZOLE; TRIMETHOPRIMSmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.